Recruiting studies: Cmv Viremia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Cent
NA · 1 location(s) · National Taiwan University Hospital · NCT07294547 Expansion of Virus-Specific Lymphocytes for Cell Therapy
Phase 1 · 1 location(s) · Hospital Israelita Albert Einstein · NCT06011486 CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Unde
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06059391 Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Phase 2/Phase 3 · 2 location(s) · Columbia University · NCT07079735 A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Pa
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT07020533 Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT07383649 Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients
Phase 2 · 1 location(s) · University Medical Centre Ljubljana · NCT05432778 Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)
Phase 2 · 7 location(s) · Murdoch Childrens Research Institute · NCT06574789 Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NA · 1 location(s) · University Hospital, Grenoble · NCT06341543

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.